US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ryder

243.13

-0.3500-0.14%

Volume:293.65K

Turnover:71.36M

Market Cap:9.32B

PE:19.73

High:244.51

Open:243.98

Low:241.50

Close:243.48

52wk High:284.25

52wk Low:157.67

Shares:38.35M

Float Shares:36.85M

Volume Ratio:1.30

T/O Rate:0.80%

Dividend:3.64

Dividend Rate:1.50%

EPS(TTM):12.33

EPS(LYR):11.94

ROE:16.70%

ROA:3.89%

PB:3.24

PE(LYR):20.37

Loading ...

Overview Company News Filings

Press Release: Beyond Air(R) Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update

Press Release: CIBC Global Asset Management Lowers Investment Minimums, and Will Terminate Certain Mutual Fund Classes

Press Release: Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

Press Release: Alliance Laundry Reports Second Quarter 2026 Results

Press Release: SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results

Press Release: Trend Micro Reports Earnings Results for Q2 2026

Press Release: Artmarket.com: Q2 2026 Upward Trend, from Progressive Transition to Artprice's "AI-First" Metamorphosis

Press Release: Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates

Press Release: Lenovo Group: Q1 Financial Results 2026/27

Press Release: Chemtrade Logistics Income Fund Announces Results for the Second Quarter of 2026 and Reiterates 2026 Adjusted Ebitda Guidance of $485 to $525 Million

Press Release: Global Crossing Airlines Reports Second Quarter 2026 Financial Results

Press Release: AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Press Release: Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update

Press Release: MaxCyte Reports Second Quarter 2026 Financial Results

Press Release: SERA Prognostics Reports Second Quarter 2026 Financial Results

Press Release: Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Press Release: SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Press Release: QT Imaging Delivers Strong Second Quarter Growth While Building the Foundation for Commercial Scale

Press Release: BioStem Technologies Reports Second Quarter 2026 Financial Results

Press Release: Alto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/R/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"R","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"R\",,,,,undefined,":{"symbol":"R","market":"US","secType":"STK","nameCN":"Ryder","latestPrice":243.13,"timestamp":1788379200000,"preClose":243.48,"halted":0,"volume":293649,"delay":0,"changeRate":-0.0014374897322161752,"floatShares":36853364,"shares":38346868,"eps":12.325055,"marketStatus":"Pre-Mkt","change":-0.35,"latestTime":"09-03 07:27:50 EDT","open":243.98,"high":244.51,"low":241.5,"amount":71356977.15708001,"amplitude":0.012362,"askPrice":244.83,"askSize":8,"bidPrice":240.95,"bidSize":8,"shortable":3,"etf":0,"ttmEps":12.325055,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788442200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":-292968000000,"exchange":"NYSE","adjPreClose":243.13,"dividendRate":0.014971,"postHourTrading":{"tag":"盘后","latestPrice":243.13,"preClose":243.13,"latestTime":"19:30 EDT","volume":51409,"amount":12499070.17,"timestamp":1788391808945,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.2963960380463522,"impliedVol":0.3036,"impliedVolPercentile":0.1275},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"R\",,,,,undefined,":{"symbol":"R","floatShares":36853364,"roa":"3.89%","roe":"16.70%","lyrEps":11.937799,"volumeRatio":1.2963960380463522,"shares":38346868,"dividePrice":3.64,"high":244.51,"amplitude":0.012362,"preClose":243.48,"low":241.5,"week52Low":157.67,"pbRate":"3.24","psRate":"0.73","week52High":284.25,"institutionHeld":0.6454,"latestPrice":243.13,"eps":12.325055,"divideRate":0.014971,"volume":293649,"delay":0,"ttmEps":12.325055,"open":243.98,"prevYearClose":191.39,"prevWeekClose":245.86,"prevMonthClose":244.46,"prevQuarterClose":263.77,"fiveDayClose":249.64,"twentyDayClose":265.54,"sixtyDayClose":270.94,"dividendPayoutRate":0.28296082308697096,"dividendFrequency":"Q","dividendGrowthYears":10,"dividendGrowthRate":0.13157894736842102,"fiveYearAvgDividendRate":0.02341379230026732},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/R\",params:#limit:5,,,undefined,":[{"date":"2026-10-22","symbol":"R","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/09","expectedEps":4.16,"defaultRemindTime":1792656000000,"name":null,"time":"Pre-MKt","dateTimestamp":1792641600000,"actualEps":null},{"date":"2026-08-24","symbol":"R","amount":1.01,"announcedDate":"2026-07-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-24","defaultRemindTime":1787578200000,"name":"瑞德系统","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-08-24","currency":"USD","dateTimestamp":1787544000000,"payDate":"2026-09-18"},{"market":"US","date":"2026-07-23","symbol":"R","fiscalQuarterEnding":"2026/06","expectedEps":3.7,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1784779200000,"reportTimeType":"pre","actualEps":3.73},{"date":"2026-05-18","symbol":"R","amount":0.91,"announcedDate":"2026-05-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-18","defaultRemindTime":1779111000000,"name":"瑞德系统","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-19","payableDate":"2026-05-18","currency":"USD","dateTimestamp":1779076800000,"payDate":"2026-06-19"},{"market":"US","date":"2026-04-23","symbol":"R","fiscalQuarterEnding":"2026/03","expectedEps":2.29,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1776916800000,"reportTimeType":"pre","actualEps":2.54}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"R\",market:\"US\",,,undefined,":[{"executeDate":"2016-11-17","recordDate":"2016-11-21","paymentDate":"2016-12-16","value":0.44,"currency":"USD"},{"executeDate":"2017-02-16","recordDate":"2017-02-21","paymentDate":"2017-03-17","value":0.44,"currency":"USD"},{"executeDate":"2017-05-18","recordDate":"2017-05-22","paymentDate":"2017-06-16","value":0.44,"currency":"USD"},{"executeDate":"2017-08-17","recordDate":"2017-08-21","paymentDate":"2017-09-15","value":0.46,"currency":"USD"},{"executeDate":"2017-11-17","recordDate":"2017-11-20","paymentDate":"2017-12-15","value":0.46,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"R\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.5,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":12,"updateTime":1784952000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/R\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"R","date":"2026-09-02","current":19.726484,"percent":0.936534,"low":4.335476,"twenty":5.686328,"median":12.170685,"eighty":15.174788,"high":21.956761,"avg":11.386823,"sd":4.634594,"marketCap":9336695420},"quantilePoints":[{"date":"2021-09-03","current":16.395895,"twenty":-7.751218,"median":9.87728,"eighty":16.767739,"marketCap":4285755840},{"date":"2021-09-10","current":16.046171,"twenty":-7.751218,"median":9.87728,"eighty":16.767739,"marketCap":4194340722},{"date":"2021-09-17","current":16.161374,"twenty":-7.751218,"median":9.87728,"eighty":16.767739,"marketCap":4224453937},{"date":"2021-09-24","current":16.916367,"twenty":-7.751218,"median":9.87728,"eighty":16.7724,"marketCap":4421803045},{"date":"2021-10-01","current":17.126202,"twenty":-7.751218,"median":9.87728,"eighty":16.824146,"marketCap":4476652116},{"date":"2021-10-08","current":17.115916,"twenty":-7.751218,"median":9.87728,"eighty":16.86858,"marketCap":4473963436},{"date":"2021-10-15","current":17.229062,"twenty":-7.751218,"median":9.87728,"eighty":16.897726,"marketCap":4503538916},{"date":"2021-10-22","current":18.296749,"twenty":-7.751218,"median":9.87728,"eighty":16.957122,"marketCap":4782623895},{"date":"2021-10-29","current":12.544258,"twenty":-7.746632,"median":9.89274,"eighty":16.972991,"marketCap":4561242691},{"date":"2021-11-05","current":12.858787,"twenty":-7.746632,"median":9.89274,"eighty":16.972991,"marketCap":4675609342},{"date":"2021-11-12","current":12.99464,"twenty":-7.746632,"median":9.89274,"eighty":16.946201,"marketCap":4725007144},{"date":"2021-11-19","current":12.432031,"twenty":-7.746632,"median":9.89274,"eighty":16.881013,"marketCap":4520435811},{"date":"2021-11-26","current":12.601848,"twenty":-7.746632,"median":9.89274,"eighty":16.848905,"marketCap":4582183064},{"date":"2021-12-03","current":11.712896,"twenty":-7.746632,"median":9.89274,"eighty":16.823699,"marketCap":4258949621},{"date":"2021-12-10","current":11.980172,"twenty":-7.746632,"median":9.89274,"eighty":16.771738,"marketCap":4356134427},{"date":"2021-12-17","current":11.548987,"twenty":-7.746632,"median":9.89274,"eighty":16.734025,"marketCap":4199350099},{"date":"2021-12-23","current":11.717326,"twenty":-7.746632,"median":9.89274,"eighty":16.724457,"marketCap":4260560419},{"date":"2021-12-31","current":12.172139,"twenty":-7.746632,"median":9.89274,"eighty":16.688297,"marketCap":4425935669},{"date":"2022-01-07","current":11.528313,"twenty":-7.742047,"median":9.894559,"eighty":16.645088,"marketCap":4191833042},{"date":"2022-01-14","current":11.66269,"twenty":-7.742047,"median":9.894559,"eighty":16.569237,"marketCap":4240693911},{"date":"2022-01-21","current":11.074978,"twenty":-7.742047,"median":9.894559,"eighty":16.518713,"marketCap":4026994725},{"date":"2022-01-28","current":10.665942,"twenty":-7.742047,"median":9.894559,"eighty":16.390958,"marketCap":3878264386},{"date":"2022-02-04","current":10.595062,"twenty":-7.742047,"median":9.894559,"eighty":16.292436,"marketCap":3852491620},{"date":"2022-02-11","current":10.866768,"twenty":-7.742047,"median":9.894559,"eighty":16.266226,"marketCap":3951287224},{"date":"2022-02-18","current":8.156002,"twenty":-7.742047,"median":9.819077,"eighty":16.167134,"marketCap":4232965038},{"date":"2022-02-25","current":8.041976,"twenty":-7.742047,"median":9.683571,"eighty":16.061394,"marketCap":4173785303},{"date":"2022-03-04","current":8.192283,"twenty":-7.742047,"median":9.408015,"eighty":15.879949,"marketCap":4251794953},{"date":"2022-03-11","current":8.208869,"twenty":-7.742047,"median":8.965509,"eighty":15.706321,"marketCap":4260402915},{"date":"2022-03-18","current":8.2995,"twenty":-7.742047,"median":8.822833,"eighty":15.524465,"marketCap":4307440377},{"date":"2022-03-25","current":7.957709,"twenty":-7.742047,"median":8.777473,"eighty":15.400744,"marketCap":4130051128},{"date":"2022-04-01","current":7.287918,"twenty":-7.742047,"median":8.581191,"eighty":15.306166,"marketCap":3782429545},{"date":"2022-04-08","current":6.216252,"twenty":-7.742047,"median":8.486348,"eighty":15.123407,"marketCap":3226235013},{"date":"2022-04-14","current":6.305886,"twenty":-7.742047,"median":8.400577,"eighty":15.064281,"marketCap":3272754960},{"date":"2022-04-22","current":6.644722,"twenty":-7.742047,"median":8.337941,"eighty":15.019858,"marketCap":3448610584},{"date":"2022-04-29","current":5.552093,"twenty":-7.742047,"median":8.266103,"eighty":15.01151,"marketCap":3574453932},{"date":"2022-05-06","current":5.903169,"twenty":-7.742047,"median":8.228212,"eighty":15.01151,"marketCap":3800478057},{"date":"2022-05-13","current":6.644243,"twenty":-7.742047,"median":8.178807,"eighty":15.01151,"marketCap":4277583282},{"date":"2022-05-20","current":6.306669,"twenty":-7.742047,"median":8.111521,"eighty":15.01151,"marketCap":4060252392},{"date":"2022-05-27","current":6.362269,"twenty":-7.742047,"median":8.052823,"eighty":15.01151,"marketCap":4096048068},{"date":"2022-06-03","current":6.481413,"twenty":-7.742047,"median":8.032181,"eighty":15.01151,"marketCap":4172753088},{"date":"2022-06-10","current":6.150194,"twenty":-7.742047,"median":8.016693,"eighty":15.01151,"marketCap":3959513132},{"date":"2022-06-17","current":5.747488,"twenty":-7.742047,"median":7.956055,"eighty":15.01151,"marketCap":3700250164},{"date":"2022-06-24","current":5.650585,"twenty":-7.746632,"median":7.945333,"eighty":15.013418,"marketCap":3637863415},{"date":"2022-07-01","current":5.726042,"twenty":-7.746632,"median":7.897499,"eighty":15.013418,"marketCap":3686443261},{"date":"2022-07-08","current":5.746694,"twenty":-7.746632,"median":7.835691,"eighty":15.013418,"marketCap":3699738798},{"date":"2022-07-15","current":5.766551,"twenty":-7.746632,"median":7.772142,"eighty":15.013418,"marketCap":3712522968},{"date":"2022-07-22","current":5.926204,"twenty":-7.746632,"median":7.442255,"eighty":15.013418,"marketCap":3815307694},{"date":"2022-07-29","current":5.461894,"twenty":-7.746632,"median":6.699881,"eighty":15.013418,"marketCap":4009565771},{"date":"2022-08-05","current":5.457013,"twenty":-7.746632,"median":6.644722,"eighty":15.013418,"marketCap":4005982145},{"date":"2022-08-12","current":5.788269,"twenty":-7.746632,"median":6.481413,"eighty":15.013418,"marketCap":4249156780},{"date":"2022-08-19","current":5.654372,"twenty":-7.746632,"median":6.388625,"eighty":15.013418,"marketCap":4150863032},{"date":"2022-08-26","current":5.604858,"twenty":-7.746632,"median":6.320172,"eighty":15.013418,"marketCap":4114514824},{"date":"2022-09-02","current":5.186429,"twenty":-7.746632,"median":6.234388,"eighty":15.013418,"marketCap":3807346864},{"date":"2022-09-09","current":5.427723,"twenty":-7.746632,"median":6.204433,"eighty":15.013418,"marketCap":3984480387},{"date":"2022-09-16","current":4.997438,"twenty":-7.746632,"median":6.039787,"eighty":15.013418,"marketCap":3668609335},{"date":"2022-09-23","current":4.66409,"twenty":-7.746632,"median":5.934147,"eighty":15.013418,"marketCap":3423898860},{"date":"2022-09-30","current":5.264535,"twenty":-7.746632,"median":5.891255,"eighty":14.984817,"marketCap":3864684883},{"date":"2022-10-07","current":5.515593,"twenty":-7.746632,"median":5.79038,"eighty":14.962577,"marketCap":4048985659},{"date":"2022-10-14","current":5.330787,"twenty":-7.746632,"median":5.747488,"eighty":14.951585,"marketCap":3913319810},{"date":"2022-10-21","current":5.177363,"twenty":-7.746632,"median":5.716511,"eighty":14.921021,"marketCap":3800691558},{"date":"2022-10-28","current":4.875682,"twenty":-7.746632,"median":5.696654,"eighty":14.896597,"marketCap":4105514216},{"date":"2022-11-04","current":4.97415,"twenty":-7.746632,"median":5.677591,"eighty":14.776301,"marketCap":4188428518},{"date":"2022-11-11","current":5.292233,"twenty":-7.746632,"median":5.663293,"eighty":14.711779,"marketCap":4456266838},{"date":"2022-11-18","current":5.380557,"twenty":-7.746632,"median":5.641848,"eighty":14.711779,"marketCap":4530638454},{"date":"2022-11-25","current":5.732059,"twenty":-7.746632,"median":5.632098,"eighty":14.711779,"marketCap":4826617386},{"date":"2022-12-02","current":5.390702,"twenty":-7.746632,"median":5.616713,"eighty":13.024764,"marketCap":4539181140},{"date":"2022-12-09","current":5.00757,"twenty":-7.746632,"median":5.60073,"eighty":12.852585,"marketCap":4216569129},{"date":"2022-12-16","current":5.043377,"twenty":-7.746632,"median":5.579284,"eighty":12.794995,"marketCap":4246719784},{"date":"2022-12-23","current":5.054119,"twenty":-7.746632,"median":5.556738,"eighty":12.683064,"marketCap":4255764981},{"date":"2022-12-30","current":4.987279,"twenty":-7.746632,"median":5.542093,"eighty":12.55727,"marketCap":4199483758},{"date":"2023-01-06","current":4.977134,"twenty":-7.746632,"median":5.530238,"eighty":12.411068,"marketCap":4190941072},{"date":"2023-01-13","current":5.452767,"twenty":-7.746632,"median":5.515593,"eighty":12.297336,"marketCap":4591442276},{"date":"2023-01-20","current":5.542284,"twenty":-7.746632,"median":5.512803,"eighty":12.262396,"marketCap":4666818914},{"date":"2023-01-27","current":5.635978,"twenty":-7.746632,"median":5.512803,"eighty":12.179012,"marketCap":4745713128},{"date":"2023-02-03","current":5.849625,"twenty":-7.746632,"median":5.504687,"eighty":12.076451,"marketCap":4925612037},{"date":"2023-02-10","current":5.754737,"twenty":-7.746632,"median":5.504687,"eighty":12.026911,"marketCap":4845712801},{"date":"2023-02-17","current":5.263255,"twenty":-7.746632,"median":5.498719,"eighty":11.969767,"marketCap":4563242372},{"date":"2023-02-24","current":5.148999,"twenty":-7.746632,"median":5.492154,"eighty":11.969767,"marketCap":4464182332},{"date":"2023-03-03","current":5.301697,"twenty":-7.746632,"median":5.485925,"eighty":11.969767,"marketCap":4596570983},{"date":"2023-03-10","current":4.857486,"twenty":-7.746632,"median":5.474851,"eighty":11.969767,"marketCap":4211440363},{"date":"2023-03-17","current":4.455455,"twenty":-7.746632,"median":5.452767,"eighty":11.969767,"marketCap":3862879398},{"date":"2023-03-24","current":4.499409,"twenty":-7.746632,"median":5.427723,"eighty":11.969767,"marketCap":3900987688},{"date":"2023-03-31","current":4.783503,"twenty":-7.742047,"median":5.424379,"eighty":11.966298,"marketCap":4147297371},{"date":"2023-04-06","current":4.522458,"twenty":-7.742047,"median":5.424379,"eighty":11.966298,"marketCap":3920971304},{"date":"2023-04-14","current":4.579277,"twenty":-7.746632,"median":5.427723,"eighty":11.969767,"marketCap":3970233240},{"date":"2023-04-21","current":4.639312,"twenty":-7.746632,"median":5.394248,"eighty":11.969767,"marketCap":4022283588},{"date":"2023-04-28","current":4.360113,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3618893391},{"date":"2023-05-05","current":4.456979,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3699292590},{"date":"2023-05-12","current":4.543916,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3771449940},{"date":"2023-05-19","current":4.544476,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3771914863},{"date":"2023-05-26","current":4.48342,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3721238329},{"date":"2023-06-02","current":4.478378,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3717054028},{"date":"2023-06-09","current":4.659306,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3867223940},{"date":"2023-06-16","current":4.628498,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3841653212},{"date":"2023-06-23","current":4.605532,"twenty":-7.751218,"median":5.393551,"eighty":11.973235,"marketCap":3822591397},{"date":"2023-06-30","current":4.710279,"twenty":-7.755803,"median":5.394248,"eighty":11.976704,"marketCap":3909531872},{"date":"2023-07-07","current":4.670509,"twenty":-7.755803,"median":5.394248,"eighty":11.976704,"marketCap":3876522387},{"date":"2023-07-14","current":4.972428,"twenty":-7.755803,"median":5.394248,"eighty":11.976704,"marketCap":4127115523},{"date":"2023-07-21","current":5.1696,"twenty":-7.755803,"median":5.394248,"eighty":11.976704,"marketCap":4290768183},{"date":"2023-07-28","current":7.905694,"twenty":-7.755803,"median":5.397863,"eighty":11.976704,"marketCap":4529962569},{"date":"2023-08-04","current":7.943832,"twenty":-7.755803,"median":5.452767,"eighty":11.976704,"marketCap":4551815654},{"date":"2023-08-11","current":8.064602,"twenty":-7.755803,"median":5.493974,"eighty":11.976704,"marketCap":4621017093},{"date":"2023-08-18","current":7.684017,"twenty":-7.755803,"median":5.519009,"eighty":11.976704,"marketCap":4402941508},{"date":"2023-08-25","current":7.629988,"twenty":-7.755803,"median":5.540699,"eighty":11.976704,"marketCap":4371982969},{"date":"2023-09-01","current":8.001039,"twenty":-7.755803,"median":5.556738,"eighty":11.976704,"marketCap":4584595283},{"date":"2023-09-08","current":7.796047,"twenty":-7.755803,"median":5.572744,"eighty":11.976704,"marketCap":4467134947},{"date":"2023-09-15","current":8.072548,"twenty":-7.755803,"median":5.598162,"eighty":11.976704,"marketCap":4625569819},{"date":"2023-09-22","current":8.255292,"twenty":-7.755803,"median":5.622292,"eighty":11.976704,"marketCap":4730282521},{"date":"2023-09-29","current":8.464257,"twenty":-7.755803,"median":5.641349,"eighty":11.976704,"marketCap":4850019220},{"date":"2023-10-06","current":7.874707,"twenty":-7.755803,"median":5.654372,"eighty":11.976704,"marketCap":4512206936},{"date":"2023-10-13","current":8.166304,"twenty":-7.755803,"median":5.677385,"eighty":11.976704,"marketCap":4679291988},{"date":"2023-10-20","current":7.969257,"twenty":-7.755803,"median":5.687122,"eighty":11.976704,"marketCap":4566384378},{"date":"2023-10-27","current":8.466638,"twenty":-7.81017,"median":5.70583,"eighty":11.984307,"marketCap":4131719492},{"date":"2023-11-03","current":8.900778,"twenty":-7.81017,"median":5.736104,"eighty":11.984307,"marketCap":4343579814},{"date":"2023-11-10","current":9.098775,"twenty":-7.81017,"median":5.748824,"eighty":11.984307,"marketCap":4440202303},{"date":"2023-11-17","current":9.541998,"twenty":-7.81017,"median":5.774024,"eighty":11.984307,"marketCap":4656494849},{"date":"2023-11-24","current":9.76815,"twenty":-7.81017,"median":5.792649,"eighty":11.984307,"marketCap":4766857234},{"date":"2023-12-01","current":9.730912,"twenty":-7.81017,"median":5.832915,"eighty":11.984307,"marketCap":4748685115},{"date":"2023-12-08","current":9.643721,"twenty":-7.785279,"median":5.902141,"eighty":11.982239,"marketCap":4706135761},{"date":"2023-12-15","current":10.11964,"twenty":-7.785279,"median":5.934147,"eighty":11.982239,"marketCap":4938384315},{"date":"2023-12-22","current":10.650962,"twenty":-7.785279,"median":6.039787,"eighty":11.982239,"marketCap":5197669436},{"date":"2023-12-29","current":10.469313,"twenty":-7.81017,"median":6.186334,"eighty":11.984307,"marketCap":5109024950},{"date":"2024-01-05","current":10.161419,"twenty":-7.835061,"median":6.212148,"eighty":11.986374,"marketCap":4958772546},{"date":"2024-01-12","current":10.035173,"twenty":-7.835061,"median":6.306669,"eighty":11.986374,"marketCap":4897164629},{"date":"2024-01-19","current":10.137805,"twenty":-7.859952,"median":6.350752,"eighty":11.988442,"marketCap":4947248763},{"date":"2024-01-26","current":10.437525,"twenty":-7.835061,"median":6.413898,"eighty":11.986374,"marketCap":5093512165},{"date":"2024-02-02","current":10.526533,"twenty":-7.835061,"median":6.548928,"eighty":11.986374,"marketCap":5136947963},{"date":"2024-02-09","current":10.603733,"twenty":-7.835061,"median":6.662452,"eighty":11.986374,"marketCap":5174621870},{"date":"2024-02-16","current":11.958272,"twenty":-7.835061,"median":6.699881,"eighty":11.992994,"marketCap":4855058498},{"date":"2024-02-23","current":12.181128,"twenty":-7.835061,"median":6.699881,"eighty":12.003352,"marketCap":4945538144},{"date":"2024-03-01","current":12.341207,"twenty":-7.81017,"median":6.732825,"eighty":12.070758,"marketCap":5010530121},{"date":"2024-03-08","current":12.549959,"twenty":-7.81017,"median":6.732825,"eighty":12.1283,"marketCap":5095283172},{"date":"2024-03-15","current":12.315273,"twenty":-7.81017,"median":6.732825,"eighty":12.192966,"marketCap":5000001022},{"date":"2024-03-22","current":12.709973,"twenty":-7.81017,"median":6.732825,"eighty":12.252055,"marketCap":5160248952},{"date":"2024-03-28","current":12.9324,"twenty":-7.81017,"median":6.732825,"eighty":12.27243,"marketCap":5250554416},{"date":"2024-04-05","current":12.824457,"twenty":-7.835061,"median":6.699881,"eighty":12.310529,"marketCap":5206729706},{"date":"2024-04-12","current":12.753586,"twenty":-7.835061,"median":6.699881,"eighty":12.337386,"marketCap":5177955906},{"date":"2024-04-19","current":11.685063,"twenty":-7.835061,"median":6.699881,"eighty":12.340342,"marketCap":4744135543},{"date":"2024-04-26","current":15.244202,"twenty":-7.81017,"median":6.732825,"eighty":12.359817,"marketCap":5365959126},{"date":"2024-05-03","current":15.528093,"twenty":-7.81017,"median":6.732825,"eighty":12.422817,"marketCap":5465888775},{"date":"2024-05-10","current":15.863035,"twenty":-7.81017,"median":6.732825,"eighty":12.516984,"marketCap":5583788228},{"date":"2024-05-17","current":15.561712,"twenty":-7.81017,"median":6.732825,"eighty":12.565399,"marketCap":5477722549},{"date":"2024-05-24","current":14.992685,"twenty":-7.81017,"median":6.732825,"eighty":12.683064,"marketCap":5277424965},{"date":"2024-05-31","current":15.007626,"twenty":-7.81017,"median":6.732825,"eighty":12.75491,"marketCap":5282684420},{"date":"2024-06-07","current":14.981478,"twenty":-7.81017,"median":6.732825,"eighty":12.826376,"marketCap":5273480373},{"date":"2024-06-14","current":14.965292,"twenty":-7.835061,"median":6.699881,"eighty":12.854653,"marketCap":5267782630},{"date":"2024-06-21","current":15.053696,"twenty":-7.859952,"median":6.696926,"eighty":12.903973,"marketCap":5298901073},{"date":"2024-06-28","current":15.257899,"twenty":-7.926764,"median":6.670331,"eighty":12.934444,"marketCap":5370780294},{"date":"2024-07-05","current":15.332607,"twenty":-7.926764,"median":6.670331,"eighty":13.078605,"marketCap":5397077570},{"date":"2024-07-12","current":15.560467,"twenty":-7.926764,"median":6.670331,"eighty":14.67393,"marketCap":5477284261},{"date":"2024-07-15","current":16.031128,"twenty":-7.926764,"median":6.670331,"eighty":14.798941,"marketCap":5642957098},{"date":"2024-08-02","current":12.046137,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5986929872},{"date":"2024-08-09","current":11.643786,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5786961567},{"date":"2024-08-16","current":11.960789,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5944512353},{"date":"2024-08-23","current":12.044395,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5986064208},{"date":"2024-08-30","current":12.267342,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6096869157},{"date":"2024-09-06","current":11.844961,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5886945719},{"date":"2024-09-13","current":11.837994,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5883483065},{"date":"2024-09-20","current":12.877836,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6400284270},{"date":"2024-09-27","current":12.605247,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6264807907},{"date":"2024-10-04","current":12.39275,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6159196940},{"date":"2024-10-11","current":12.762878,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6343150468},{"date":"2024-10-18","current":12.754684,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6339078000},{"date":"2024-10-25","current":12.285395,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5872418977},{"date":"2024-10-31","current":13.170128,"twenty":-8.0879,"median":6.543636,"eighty":14.807159,"marketCap":6295321107},{"date":"2024-11-08","current":14.050437,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6716108726},{"date":"2024-11-15","current":14.657363,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":7006219587},{"date":"2024-11-22","current":14.262772,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6817605237},{"date":"2024-11-29","current":14.937823,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":7140279562},{"date":"2024-12-06","current":14.566236,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6962660668},{"date":"2024-12-13","current":14.75026,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":7050624311},{"date":"2024-12-20","current":13.771746,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6582894555},{"date":"2024-12-27","current":14.153066,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6765165373},{"date":"2025-01-03","current":13.844294,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6617572530},{"date":"2025-01-10","current":14.016817,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":6700038445},{"date":"2025-01-17","current":14.647631,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":7001567664},{"date":"2025-01-24","current":14.644977,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":7000298957},{"date":"2025-01-31","current":14.36894,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":6868353493},{"date":"2025-02-07","current":13.879683,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":6634488615},{"date":"2025-02-14","current":13.862207,"twenty":-8.03386,"median":6.543636,"eighty":13.316137,"marketCap":6778619352},{"date":"2025-02-21","current":14.292524,"twenty":-7.746632,"median":6.652028,"eighty":13.787317,"marketCap":6989043992},{"date":"2025-02-28","current":13.739137,"twenty":-7.30351,"median":6.732825,"eighty":13.829167,"marketCap":6718437905},{"date":"2025-03-07","current":13.320009,"twenty":-6.938007,"median":7.55689,"eighty":13.830759,"marketCap":6513484306},{"date":"2025-03-14","current":11.737306,"twenty":-6.885604,"median":7.691962,"eighty":13.830759,"marketCap":5739542480},{"date":"2025-03-21","current":11.989848,"twenty":-6.794229,"median":7.780156,"eighty":13.830759,"marketCap":5863035670},{"date":"2025-03-28","current":12.289466,"twenty":-6.704491,"median":7.818294,"eighty":13.830759,"marketCap":6009548949},{"date":"2025-04-04","current":11.830222,"twenty":-6.612788,"median":7.905144,"eighty":13.830759,"marketCap":5784978738},{"date":"2025-04-11","current":11.83449,"twenty":-6.460167,"median":7.944627,"eighty":13.830628,"marketCap":5787065822},{"date":"2025-04-17","current":11.790103,"twenty":-6.392044,"median":7.965682,"eighty":13.830628,"marketCap":5765360151},{"date":"2025-04-25","current":11.457658,"twenty":-6.145958,"median":8.001039,"eighty":13.830759,"marketCap":5751744390},{"date":"2025-05-02","current":11.438717,"twenty":-5.907983,"median":8.021733,"eighty":13.830759,"marketCap":5742236008},{"date":"2025-05-09","current":12.069535,"twenty":4.422322,"median":8.052268,"eighty":13.830759,"marketCap":6058906475},{"date":"2025-05-16","current":12.972115,"twenty":4.465495,"median":8.071753,"eighty":13.830759,"marketCap":6512001555},{"date":"2025-05-23","current":12.379179,"twenty":4.482002,"median":8.092411,"eighty":13.830759,"marketCap":6214347853},{"date":"2025-05-30","current":12.411296,"twenty":4.504369,"median":8.124987,"eighty":13.830759,"marketCap":6230470762},{"date":"2025-06-06","current":12.205416,"twenty":4.52924,"median":8.150819,"eighty":13.830759,"marketCap":6127118782},{"date":"2025-06-13","current":12.324003,"twenty":4.54414,"median":8.183784,"eighty":13.830759,"marketCap":6186649522},{"date":"2025-06-20","current":12.475531,"twenty":4.557695,"median":8.223114,"eighty":13.830891,"marketCap":6262716580},{"date":"2025-06-27","current":13.078349,"twenty":4.57381,"median":8.253849,"eighty":13.830891,"marketCap":6565331177},{"date":"2025-07-03","current":14.129163,"twenty":4.586262,"median":8.30557,"eighty":13.858624,"marketCap":7092839683},{"date":"2025-07-11","current":14.494806,"twenty":4.600504,"median":8.337941,"eighty":13.890852,"marketCap":7276392799},{"date":"2025-07-18","current":14.164574,"twenty":4.608827,"median":8.434859,"eighty":13.981782,"marketCap":7110616224},{"date":"2025-07-25","current":14.307417,"twenty":4.625011,"median":8.858999,"eighty":14.002789,"marketCap":7225245354},{"date":"2025-08-01","current":14.354265,"twenty":4.633104,"median":9.160989,"eighty":14.049906,"marketCap":7248903923},{"date":"2025-08-08","current":14.19918,"twenty":4.650193,"median":9.572878,"eighty":14.097858,"marketCap":7170585902},{"date":"2025-08-15","current":14.709669,"twenty":4.666003,"median":9.666427,"eighty":14.127845,"marketCap":7428382721},{"date":"2025-08-22","current":14.573161,"twenty":4.709831,"median":9.71638,"eighty":14.151964,"marketCap":7359446547},{"date":"2025-08-29","current":15.114344,"twenty":4.783503,"median":9.76815,"eighty":14.198571,"marketCap":7632743808},{"date":"2025-09-05","current":15.23712,"twenty":4.812786,"median":9.833544,"eighty":14.238885,"marketCap":7694745575},{"date":"2025-09-12","current":15.312239,"twenty":4.861125,"median":10.041985,"eighty":14.314092,"marketCap":7732680866},{"date":"2025-09-19","current":14.993992,"twenty":4.931659,"median":10.156878,"eighty":14.354103,"marketCap":7571965760},{"date":"2025-09-26","current":14.909987,"twenty":4.960305,"median":10.2309,"eighty":14.420027,"marketCap":7529543499},{"date":"2025-10-03","current":15.384936,"twenty":4.977731,"median":10.32899,"eighty":14.468748,"marketCap":7769392438},{"date":"2025-10-10","current":14.883332,"twenty":4.997531,"median":10.44025,"eighty":14.503112,"marketCap":7516082589},{"date":"2025-10-17","current":14.752479,"twenty":5.035793,"median":10.493382,"eighty":14.525335,"marketCap":7450001759},{"date":"2025-10-24","current":12.89259,"twenty":5.054716,"median":10.599398,"eighty":14.539205,"marketCap":6472080000},{"date":"2025-10-31","current":13.625069,"twenty":5.097183,"median":10.658452,"eighty":14.539205,"marketCap":6839784859},{"date":"2025-11-07","current":13.479489,"twenty":5.12209,"median":10.73345,"eighty":14.539205,"marketCap":6766703333},{"date":"2025-11-14","current":13.617026,"twenty":5.133219,"median":10.893348,"eighty":14.539205,"marketCap":6835747206},{"date":"2025-11-21","current":13.070093,"twenty":5.152815,"median":11.090483,"eighty":14.539205,"marketCap":6561186775},{"date":"2025-11-28","current":13.873602,"twenty":5.177781,"median":11.196803,"eighty":14.539205,"marketCap":6964548349},{"date":"2025-12-05","current":14.478446,"twenty":5.19145,"median":11.302112,"eighty":14.539205,"marketCap":7268179885},{"date":"2025-12-12","current":15.927014,"twenty":5.207168,"median":11.404144,"eighty":14.629582,"marketCap":7995361262},{"date":"2025-12-19","current":15.296433,"twenty":5.254517,"median":11.451225,"eighty":14.655417,"marketCap":7678809236},{"date":"2025-12-26","current":15.906907,"twenty":5.265027,"median":11.491086,"eighty":14.698585,"marketCap":7985267129},{"date":"2026-01-02","current":15.393755,"twenty":5.303504,"median":11.530528,"eighty":14.710447,"marketCap":7727664842},{"date":"2026-01-09","current":15.285172,"twenty":5.326043,"median":11.631919,"eighty":14.756356,"marketCap":7673156521},{"date":"2026-01-16","current":15.624593,"twenty":5.335095,"median":11.673876,"eighty":14.821626,"marketCap":7843545494},{"date":"2026-01-23","current":15.790281,"twenty":5.381631,"median":11.714373,"eighty":14.842245,"marketCap":7926721154},{"date":"2026-01-30","current":15.476599,"twenty":5.397735,"median":11.740952,"eighty":14.909825,"marketCap":7769252672},{"date":"2026-02-06","current":17.236437,"twenty":5.43372,"median":11.783021,"eighty":14.940109,"marketCap":8652691236},{"date":"2026-02-13","current":16.435376,"twenty":5.467946,"median":11.830222,"eighty":14.977245,"marketCap":8201252704},{"date":"2026-02-20","current":17.329797,"twenty":5.50631,"median":11.845396,"eighty":14.992461,"marketCap":8647568653},{"date":"2026-02-27","current":17.630044,"twenty":5.529122,"median":11.868324,"eighty":15.006515,"marketCap":8797392028},{"date":"2026-03-06","current":16.622636,"twenty":5.543836,"median":11.926274,"eighty":15.027061,"marketCap":8294695177},{"date":"2026-03-13","current":14.692322,"twenty":5.566305,"median":11.961621,"eighty":15.051953,"marketCap":7331468705},{"date":"2026-03-20","current":15.122092,"twenty":5.582426,"median":12.000539,"eighty":15.06114,"marketCap":7545923966},{"date":"2026-03-27","current":15.704285,"twenty":5.607776,"median":12.030258,"eighty":15.075828,"marketCap":7836438314},{"date":"2026-04-02","current":16.252694,"twenty":5.634545,"median":12.044612,"eighty":15.114182,"marketCap":8110094204},{"date":"2026-04-10","current":17.445365,"twenty":5.643595,"median":12.073512,"eighty":15.122356,"marketCap":8705236958},{"date":"2026-04-17","current":17.393509,"twenty":5.667538,"median":12.105673,"eighty":15.140077,"marketCap":8679361186},{"date":"2026-04-24","current":19.000109,"twenty":5.68188,"median":12.153841,"eighty":15.16364,"marketCap":9386054056},{"date":"2026-05-01","current":19.875748,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":9818619637},{"date":"2026-05-08","current":18.939802,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":9356261972},{"date":"2026-05-15","current":18.097058,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":8939946619},{"date":"2026-05-22","current":18.675857,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":9225873242},{"date":"2026-05-29","current":19.487272,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":9626712188},{"date":"2026-06-05","current":20.75217,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":10251572129},{"date":"2026-06-12","current":21.956761,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":10846639986},{"date":"2026-06-18","current":20.841457,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":10295679889},{"date":"2026-06-26","current":20.984003,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10366097542},{"date":"2026-07-02","current":20.833625,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10291810788},{"date":"2026-07-10","current":21.117934,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10432259183},{"date":"2026-07-17","current":21.386578,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10564969375},{"date":"2026-07-24","current":20.671045,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10273509405},{"date":"2026-07-31","current":19.919539,"twenty":5.686328,"median":12.170685,"eighty":15.172062,"marketCap":9900010911},{"date":"2026-08-07","current":20.237425,"twenty":5.686328,"median":12.170685,"eighty":15.172062,"marketCap":10058000007},{"date":"2026-08-14","current":20.305322,"twenty":5.686328,"median":12.170685,"eighty":15.172062,"marketCap":10091745251},{"date":"2026-08-21","current":19.123282,"twenty":5.686328,"median":12.170685,"eighty":15.174788,"marketCap":9504271233},{"date":"2026-08-28","current":19.1418,"twenty":5.686328,"median":12.170685,"eighty":15.174788,"marketCap":9513474482},{"date":"2026-09-02","current":18.786107,"twenty":5.686328,"median":12.170685,"eighty":15.174788,"marketCap":9336695420}],"updateTime":1788431466562},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"R\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659568431","title":"Press Release: Beyond Air(R) Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659568431","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659568431?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618800,"startTime":"0","endTime":"0","summary":"partners.Financial Results for the Quarter Ended June 30, 2026Revenues for the quarters ended June 30, 2026 and 2025 were $1.8 million.Gross margins for the quarter ended June 30, 2026 were 13%, compared to 9% for the same period last year.Research and development expenses for the quarter ended June 30, 2026 were $2.0 million, compared with $3.1 million for the same period last year.Selling, general and administrative expenses for the quarter ended June 30, 2026 were $4.9 million, compared with $4.7 million for the same period last year.Other expense for the quarter ended June 30, 2026 was $1.5 million, compared with $0.5 million for the same period last year.Net loss attributable to co","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4232","BK4588","LABU","BK4022","BK4082","XAIR","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659315635","title":"Press Release: CIBC Global Asset Management Lowers Investment Minimums, and Will Terminate Certain Mutual Fund Classes","url":"https://stock-news.laohu8.com/highlight/detail?id=2659315635","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659315635?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618800,"startTime":"0","endTime":"0","summary":"TORONTO, August 13, 2026 /CNW/ -- CIBC   -- CIBC Global Asset Management  today announced changes to its product lineup, including lower investment minimums and terminations for certain mutual fund classes. These changes are part of CIBC GAM's ongoing commitment to simplify its fund offerings and ensure clients access investment solutions that best meet their financial goals.Lower initial investment minimumsEffective August 13, 2026, the minimum initial investment for the following investment solutions will be reduced:-- The minimum investment for the CIBC Real Assets Private Pool has been. -- The minimum initial investment for all other CIBC Private Pools has been. reduced to $500 from $100,000.Termination of several mutual fund classesTo simplify its product offering, CIBC GAM is terminating several mutual fund classes with relatively small asset sizes.Effective immediately, classes designated for termination will be closed to new purchases, including purchases through regular invest","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","BK4555","03160","BK4022","TM","BK4099","BK4585","BK4207","R","BK4588","CM","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156389","title":"Press Release: Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156389","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156389?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618800,"startTime":"0","endTime":"0","summary":"Phase 1 monotherapy study for 2L+ R/M HNSCC in Fall 2026. The update is. expected to include patients treated at 5.4 mg/kg IV Q3W with a dose. equivalent to or below a dose cap, together with detailed analyses of the. dose cap impact on safety, tolerability, efficacy and initial durability.-- The Company completed target enrollment in the Phase 1 Part 2. monotherapy dose expansion study in the first quarter of 2026.-- The ongoing MICVO Phase 1 monotherapy study is a multi-part study.Part 1 was a dose escalation study across multiple doses and tumor. types, with initial results shared in November 2024. Part 2, a. dose expansion study in 2L+ R/M HNSCC, is currently ongoing.Preliminary Phase 1 study results in 2L+ R/M HNSCC were shared in. December 2025, supporting MICVO's broad potential to address a. significant unmet need for patients regardless of HPV status or","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","LU0053666078.USD","BK4139","BK4080","NETL","LU0210528500.USD","LU2487616109.SGD","L","PYXS","BK4107","BK4588","BK4022","BK4585","R","BK4231","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156365","title":"Press Release: Alliance Laundry Reports Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156365","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156365?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618800,"startTime":"0","endTime":"0","summary":"Second Quarter 2026 Highlights:All results are for the second quarter of fiscal 2026, and comparisons are year-over-year unless otherwise noted--  Net revenue of $477 million, up 7%. --  Net income of $69 million, an increase of 121%; Adjusted Net income of. --  Repaid $50 million in debt; Net Leverage reduced to 2.4x. --  Raises full year 2026 Adjusted EBITDA guidance to +8% to 10% growth. reconciliation of non-GAAP measures is contained in the appendix to this press","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","BK4232","BK4022","R","ALH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659153014","title":"Press Release: SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659153014","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659153014?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:30","pubTimestamp":1786617000,"startTime":"0","endTime":"0","summary":"Restructuring Complete, Growth Reaccelerates: Q2 Revenue Up 13%, Net Income Attributable to SBC Medical Up 335%, Adjusted EBITDA Up 32% Year-over-Year. AI-Enabled Service Enhancements Drive Successful Fee Increases, Positioning the Business for Accelerated Network ExpansionIRVINE, Calif.----August 13, 2026--SBC Medical Group Holdings Incorporated  , a Medical Services Organization  providing management support across a wide range of healthcare fields to medical institutions in Japan and abroad, today announced its consolidated financial results for the second quarter of fiscal year 2026  and the first half of fiscal year 2026 .Second Quarter 2026 Financial Highlights--  Total revenues were $49 million, an increase of 13% year-over-year.335% year-over-year. Net income margin was 22%, an increase of 16. Adjusted EBITDA margin1 was 41%, an increase of 6 percentage points","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","ARTY","ROE","QTOC","BK4022","AGIX","BK4232","SBC","BK4196","AIPO","CHAT","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659813797","title":"Press Release: Trend Micro Reports Earnings Results for Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659813797","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659813797?lang=en_us&edition=fundamental","pubTime":"2026-08-13 17:00","pubTimestamp":1786611600,"startTime":"0","endTime":"0","summary":"-- Increase of 13% YoY in total company net sales*, driving U.S. $1.7. -- Increase of 49% YoY in TrendAI Vision One ARR, contributing to total. enterprise ARR surpassing U.S. $1.3 Billion, up 6% YoY**. -- Increase of 52% YoY in Digital Life Protection ARR, fueling consumer ARR","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHAT","UCYB","R","BK4022","PSWD","QTOC","BK4232","ARR","ARTY","BK4555","AGIX","BK4585","TM","BK4588","VTHR","BK4097","REM","03160","BK4099","BK4110","MORT","AIPO","SPAM","TMICY","BK4604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659313388","title":"Press Release: Artmarket.com: Q2 2026 Upward Trend, from Progressive Transition to Artprice's \"AI-First\" Metamorphosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2659313388","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659313388?lang=en_us&edition=fundamental","pubTime":"2026-08-13 13:15","pubTimestamp":1786598100,"startTime":"0","endTime":"0","summary":"PARIS, Aug. 13, 2026 /PRNewswire/ -- Thierry EHRMANN, Founder of Artprice and CEO of Artmarket.com, and his family have full confidence in the future of Artmarket.com and in the growth of its activities, driven notably by substantial investments dedicated to the development of Artmarket.com's vertical AI. The expression of support from the Ehrmann family and Groupe Serveur  for the expansion of Artmarket.com's business will materialize very shortly through an increase in their shareholding in Artmarket.com via the acquisition of additional Artmarket.com shares. Naturally, all required disclosures will be made to the AMF  and online within legal deadlines during authorized trading windows.News and OutlookFrom Progressive Transition to the \"AI-FIRST\" Metamorphosis of the Artprice Meta-DatabaseFollowing an in-depth strategic review approved by the Board of Directors, Artprice--the global leader in art market information for nearly three decades--is executing a major doctrinal shift in the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1235295455.SGD","LU1599440770.SGD","SG9999003800.SGD","IE00B7KXQ091.USD","LU1481011911.USD","VTHR","IE0004445239.USD","LU0731783394.SGD","SG9999004303.SGD","BK4588","IE00BJJMRY28.SGD","LU0175139822.USD","IE00BKVL7J92.USD","IAK","AIPO","AGIX","BK4533","BK4107","IE00BJJMRX11.SGD","LU0289960550.SGD","LU0354030438.USD","BK4232","LU0353189680.USD","IE00B4JS1V06.HKD","LU1035773651.USD","LU2108987350.USD","LU2087625088.SGD","LU1267930227.SGD","KBWP","LU0138981039.USD","IE00BZ1G4Q59.USD","LU1585245621.USD","IE00BFSS7M15.SGD","BK4022","R","QTOC","ARTY","SG9999011175.SGD","LU0731783048.USD","IE00BN29S564.USD","IE0005OL40V9.USD","LU0742537680.HKD","PGR","LU0128525689.USD","IE00B775H168.HKD","LU2355687059.USD","LU0070302665.USD","LU1069347547.HKD","CHAT","LU0052756011.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659138453","title":"Press Release: Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2659138453","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659138453?lang=en_us&edition=fundamental","pubTime":"2026-08-13 13:00","pubTimestamp":1786597200,"startTime":"0","endTime":"0","summary":"-- In-line with expectations; full-year guidance of EUR135 -150. -- Solid cash position of EUR121.5 million as of end June 2026. -- Reflects disciplined cash management and proceeds from the recent. -- Restructuring program implemented with positive P&L and cash flow. impacts expected in the second half of the year and beyond. -- Regulatory decisions for Lyme disease vaccine candidate expected in the. -- Pfizer remains optimistic about obtaining registration for the. sales, compared with EUR97.6 million and EUR91.0 million, respectively,in the first half of 2025. The year-over-year decrease primarily reflects. the planned wind-down of third-party sales (down EUR10.5 million versus. the first half of 2025) and the expected phasing of product sales,EUR109.7 million as of December 31, 2025. This strong cash position. reflects the positive impact of restructuring initiatives, disciplined. cash management and EUR37 million in gross proceeds from the successful. in the first half of 2025, re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4022","EMA","BK4232","CHIM","BK4539","R","BK4081","VALN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659180784","title":"Press Release: Lenovo Group: Q1 Financial Results 2026/27","url":"https://stock-news.laohu8.com/highlight/detail?id=2659180784","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659180784?lang=en_us&edition=fundamental","pubTime":"2026-08-13 12:16","pubTimestamp":1786594560,"startTime":"0","endTime":"0","summary":"Lenovo delivers strongest quarter in Group history: Hybrid AI strategy powers growth momentumHONG KONG--(BUSINESS WIRE)--August 13, 2026--Lenovo Group Limited (HKSE: 992) (ADR: LNVGY), together with i","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306701.USD","BK1193","BK1526","HK0000320223.HKD","LU0320764755.SGD","LU0543330483.HKD","LU2242644610.SGD","LU0791590937.USD","LU0862451753.SGD","AGIX","LU0310800965.SGD","BK4588","LU0572940350.SGD","BK4604","LU0029875118.USD","BK4232","BK1607","HK0000306685.HKD","IE0032431581.USD","03160","LU0264606111.USD","LU1267930227.SGD","BK4585","BK4099","LU1046422090.SGD","IE0034224299.USD","IE0003895053.USD","LU0128525689.USD","LU0370786039.SGD","LU0572939691.SGD","TCHI","LU0052756011.USD","VTHR","BK4022","BK4555","BK4170","CHAT","IE00B0JY6N72.USD","80992","AIPO","SSG","R","ARTY","LNVGY","00992","QTOC","TM","LU0890818403.SGD","LU0048580855.USD","LU0791591158.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659185283","title":"Press Release: Chemtrade Logistics Income Fund Announces Results for the Second Quarter of 2026 and Reiterates 2026 Adjusted Ebitda Guidance of $485 to $525 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659185283","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659185283?lang=en_us&edition=fundamental","pubTime":"2026-08-13 06:00","pubTimestamp":1786572000,"startTime":"0","endTime":"0","summary":"year-over-year driven by the Polytec acquisition in the WS segment as. well as higher selling prices for merchant acid, sulphur products and. Regen acid in the ASP segment. This more than offset lower selling prices. of chlor-alkali products and lower volumes and selling prices for sodium. --  Adjusted EBITDA of $127.3 million, a decrease of $10.7 million or. at North Vancouver, Adjusted EBITDA was $3.7 million lower than 2025.Adjusted EBITDA from the Polytec acquisition and higher Adjusted EBITDA. from merchant and Regen acid were more than offset by lower selling. prices for chlor-alkali products and lower volumes and selling prices for. sodium chlorate. Adjusted EBITDA for water products was also lower as. higher selling prices did not fully offset higher input costs.year-over-year primarily due to an impairment of PPE in 2025 and lower. finance costs that were partially offset by lower Adjusted EBITDA,unfavourable unrealized foreign exchange losses, higher depreciation and. year. C","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACH","BK4090","WS","BK4232","BK4022","CGIFF","R","BK4006","BK4175","BK4153","SWC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659889471","title":"Press Release: Global Crossing Airlines Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659889471","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659889471?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:44","pubTimestamp":1786567440,"startTime":"0","endTime":"0","summary":"Improved Fleet Efficiency and Aircraft Utilization Drive EBITDA Growth Despite Fewer Net Available AircraftAdvances Fleet Modernization Initiative with Five New A320 Aircraft -- On Track to Reach 25-Aircraft Target by Year-EndMIAMI, Aug. 12, 2026  -- Global Crossing Airlines Group, Inc.  , The Nation's Fastest Growing Charter Airline , today announced its financial and operating results for the second quarter ended June 30, 2026. Except as otherwise disclosed, all figures are presented in United States dollars and prepared in accordance with U.S. GAAP.Financial and Operational Summary. ------------------------------------------  -------  -------  --------Management Commentary\"GlobalX delivered a solid second quarter, with results highlighting the resilience of our platform,\" said Chris Jamroz, Executive Chairman of GlobalX. \"Despite a period of highly intensified scheduled maintenance that meaningfully constrained aircraft availability, we maintained year-over-year revenue and delivere","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JETMF","BK4008","R","BK4232","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659990095","title":"Press Release: AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659990095","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659990095?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:15","pubTimestamp":1786565700,"startTime":"0","endTime":"0","summary":"-- AEON held a successful Biosimilar Biological Product Development.  Type 2a meeting with the U.S. Food and Drug Administration.  during the first quarter of 2026. During the meeting, the. strategy under the 351 biosimilar pathway and provided feedback. ABP-450. Collectively, the FDA's feedback provided AEON with. well-defined direction and a framework for the remaining. analytical components of its biosimilar development program. The. associated with characterizing the 900 kDa botulinum neurotoxin. complex due to its large size and exceptional potency, while. analytical assessment plan. The Company looks forward to feedback. from its planned BPD Type 2b interaction with the FDA in the. second half of 2026, which is expected to help inform the next. phase of development for ABP-450, including clinical pharmacology. -- Strengthened Balance Sheet through a $15.3 Million Financing with","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4232","BK4588","BBP","AEON","LABU","BK4139","BK4022","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907259","title":"Press Release: Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907259","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907259?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"-- On track for September 2026 top-line results from Phase 2b clinical trial.  evaluating laromestrocel as a potential adjunct treatment for. hypoplastic left heart syndrome , a rare pediatric disease and. -- Longeveron selected as a Finalist and Milestone 2 Awardee for the XPRIZE. Healthspan competition based on published clinical trial results which. indicated laromestrocel increased 6-minute walk distance in patients with. -- Three new independent Directors join Longeveron's Board of Directors. laromestrocel as a potential adjunct therapy for HLHS are anticipated in. -- In May, the Company announced that the U.S. Food and Drug Administration.  held a Type C meeting in late March 2026 focused on the ELPIS II. Phase 2b clinical trial and upcoming data readout.-- Also in May, the Company announced that the independent Data Monitoring. Committee  completed its final prespecified data review for ELPIS II. Phase 2b clinical trial . The DMC performed a risk-benefit. assessment, indicated n","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4232","LGVN","EMA","MEDX","AD","GDOC","IDNA","NVIB","DMC","R","BK4022","HYLG","BK4189","BK4081","BK4132","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907077","title":"Press Release: MaxCyte Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907077","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907077?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"-- Reports total revenue of $7.3 million for the second quarter of 2026,including $6.5 million of core revenue and $0.8 million of SPL. -- Repurchased approximately $5.5 million of common stock to date under the. Company's $10 million share repurchase program authorized by the Board. -- Following end of quarter, announced strategic, multi-platform technology. of 15% over the second quarter of 2025.-- Core business revenue of $6.5 million in the second quarter of. million for the second quarter of 2026, compared to $0.3 million. -- Gross profit for the second quarter of 2026 was $5.6 million (77% gross. revenue and reserves for excess and obsolete inventory, compared to. non-GAAP adjusted gross margin of 83% in the second quarter of 2025.-- Operating expenses for the second quarter of 2026 were $15.8 million,-- Second quarter 2026 net loss was $8.9 million compared to net loss of","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","TM","BK4604","03160","BK4539","MXCT","BK4022","R","BK4099","BK4588","BK4585","BK4232","BK4555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907036","title":"Press Release: SERA Prognostics Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907036","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907036?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Aug. 12, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company , focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the second quarter ended June 30, 2026.Key Second Quarter and Recent Highlights:-- Advanced Commercial Adoption Strategy with Fourth Partnership Program. Launch: In August 2026, we launched fourth partnership program, expanding. implementation of PreTRM Test-guided care through a state-based. initiative with a national payer. We also exceeded our 2026 payer. engagement objective, with active discussions now spanning more than 20. payer opportunities across over 20 states, and are increasingly focused. on advancing implementation, reimbursement readiness, and adoption within. -- Illinois Medicaid Coverage Mandate Expands Access to PreTRM-Test: In June. requiring Medicaid coverage and reimbursement for prescribed proteomic. blood ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","R","SERA","BK4022","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659463907","title":"Press Release: Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659463907","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659463907?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"Phase 3 C-BEYOND Trial Met Primary and Secondary Endpoints, with a Short 8-week Duration for Patients Without Cirrhosis Supporting a Potential Best-in-Class Profile of BEM/RZR for Treatment of HCVC-FO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDC","BK4007","AVIR","BK4232","BK4022","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659385900","title":"Press Release: SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2659385900","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659385900?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"AKI, adding 3 new customers from top-rated children's hospitals, bringing. the total customer base to 20 and building increased depth in customer. orders. This led to second quarter 2026 net revenue of $0.6 million for. QUELIMMUNE product sales, an increase of 82% versus the second quarter of. -- Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial. evaluating the SCD therapy as a potential treatment of adult patients. with AKI in the ICU receiving continuous renal replacement therapy. The. trial has enrolled 223 of 339 patients to date. Completion of enrollment. is anticipated around year end or into the first quarter of 2027, which. would enable a PMA application to the FDA near the end of 2027, pending a. -- Received from the Centers for Medicare & Medicaid Services ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","CMS","BK4082","BK4022","LU1003077747.HKD","LU1894683264.USD","BK4208","ICU","LU0738911758.USD","LU2346227817.USD","BK4129","LU2637428348.USD","LU0949170772.SGD","R","BK4232","LU2500361329.USD","BK4585","SCD","LU1894683348.USD","LU0661504455.SGD","LU0553294199.USD","LU0545039389.USD","PMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659090722","title":"Press Release: QT Imaging Delivers Strong Second Quarter Growth While Building the Foundation for Commercial Scale","url":"https://stock-news.laohu8.com/highlight/detail?id=2659090722","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659090722?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"CT scanners during the second quarter of 2026 and 28 scanners during the. first six months of the year. The revenue for the second quarter of 2026. was $7.4 million. The Company continues to pursue commercial. opportunities through a combination of established distribution partners","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4588","TM","QTI","BK4082","BK4604","BK4099","BK4555","R","BK4022","BK4232","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659042907","title":"Press Release: BioStem Technologies Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659042907","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659042907?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"Generates 29% sequential revenue growth, increasing to $7.9 million;Raises full-year 2026 revenue guidanceUplists to Nasdaq Capital MarketPOMPANO BEACH, Fla., Aug. 12, 2026  -- BioStem Technologies, Inc. , a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today reported financial results for the second quarter ended June 30, 2026.Recent Corporate Highlights-- Completed the uplisting of the Company's common stock to the Nasdaq. -- Completed a $2.5 million private placement with the Company's first. representing sequential growth of 29% from $6.1 million in the first. -- Continued to scale the commercial organization, expanding the direct. sales force, integrating the CRM and ERP systems, and transitioning all. major group purchasing organization  agreements to broaden access. -- Issued eight new U.S. design patents covering fenestrated human placental","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4588","TM","BK4022","BSEM","BK4604","BK4099","BK4555","R","BK4007","BK4232","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907649","title":"Press Release: Alto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907649","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907649?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:03","pubTimestamp":1786564980,"startTime":"0","endTime":"0","summary":"double-blind, placebo-controlled trial conducted by investigators at Lund. University, Sweden -- were published in Nature Medicine. Adults with","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4007","R","ANRO","BK4232"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}